New research offers a window into a promising new class of anti-cancer drugs

New research offers a window into a promising new class of anti-cancer drugs

Anti-cancer drugs called nutlins are in early clinical trials, but an important question about them has lingered until now: Do they kill blood cancer cells, or just suppress them for a while? Now Australian researchers have discovered that nutlins

(Visited 1 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.